RWS
BBIO icon

Retirement Wealth Solutions’s BridgeBio Pharma BBIO Stock Holding History

Retirement Wealth Solutions’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64K Sell
22
-2
-8% -$140 ﹤0.01% 557
2026
Q1 		$1.78K Buy
24
+1
+4% +$72 ﹤0.01% 527
2025
Q4 		$1.76K Buy
+23
New +$1.51K ﹤0.01% 481

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Retirement Wealth Solutions's BBIO Position: Q2 2026 in Review

Retirement Wealth Solutions reduced its BridgeBio Pharma (BBIO) stake by 8.3% in Q2 2026, selling an estimated $140 and leaving 22 shares worth $1.64K. The position accounts for ﹤0.01% of the portfolio, ranked #557.

Retirement Wealth Solutions first reported a position in BBIO in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.78K in Q1 2026. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Retirement Wealth Solutions held 22 shares of BridgeBio Pharma worth $1.64K as of Q2 2026.
  • Retirement Wealth Solutions sold 2 BridgeBio Pharma shares in Q2 2026, an estimated $140.
  • BridgeBio Pharma made up ﹤0.01% of Retirement Wealth Solutions's portfolio in Q2 2026, its #557 holding.
  • Retirement Wealth Solutions first reported a position in BridgeBio Pharma in Q4 2025 and has held it in 3 quarters since.
  • Retirement Wealth Solutions's BridgeBio Pharma position peaked at $1.78K in Q1 2026.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Retirement Wealth Solutions's 13F filing for Q2 2026, filed 7 Jul 2026.